LeMaitre Vascular ROA 2007-2019 | LMAT
Current and historical return on assets (ROA) values for LeMaitre Vascular (LMAT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. LeMaitre Vascular ROA for the three months ending September 30, 2019 was 11.25%.
| LeMaitre Vascular ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2019-09-30 | $0.02B | $0.17B | 12.38% |
| 2019-06-30 | $0.02B | $0.16B | 12.26% |
| 2019-03-31 | $0.02B | $0.16B | 15.49% |
| 2018-12-31 | $0.02B | $0.15B | 16.34% |
| 2018-09-30 | $0.02B | $0.14B | 15.67% |
| 2018-06-30 | $0.02B | $0.14B | 17.15% |
| 2018-03-31 | $0.02B | $0.13B | 14.75% |
| 2017-12-31 | $0.02B | $0.13B | 14.59% |
| 2017-09-30 | $0.02B | $0.12B | 14.48% |
| 2017-06-30 | $0.01B | $0.11B | 13.27% |
| 2017-03-31 | $0.01B | $0.11B | 11.82% |
| 2016-12-31 | $0.01B | $0.10B | 11.22% |
| 2016-09-30 | $0.01B | $0.10B | 11.55% |
| 2016-06-30 | $0.01B | $0.10B | 10.90% |
| 2016-03-31 | $0.01B | $0.09B | 10.17% |
| 2015-12-31 | $0.01B | $0.09B | 9.38% |
| 2015-09-30 | $0.01B | $0.09B | 8.46% |
| 2015-06-30 | $0.01B | $0.08B | 7.32% |
| 2015-03-31 | $0.01B | $0.08B | 6.13% |
| 2014-12-31 | $0.00B | $0.08B | 5.08% |
| 2014-09-30 | $0.00B | $0.08B | 3.95% |
| 2014-06-30 | $0.00B | $0.08B | 4.18% |
| 2014-03-31 | $0.00B | $0.07B | 4.44% |
| 2013-12-31 | $0.00B | $0.07B | 6.06% |
| 2013-09-30 | $0.00B | $0.07B | 6.23% |
| 2013-06-30 | $0.00B | $0.06B | 6.37% |
| 2013-03-31 | $0.00B | $0.06B | 6.48% |
| 2012-12-31 | $0.00B | $0.06B | 4.94% |
| 2012-09-30 | $0.00B | $0.06B | 3.33% |
| 2012-06-30 | $0.00B | $0.06B | 3.31% |
| 2012-03-31 | $0.00B | $0.06B | 3.28% |
| 2011-12-31 | $0.00B | $0.06B | 3.25% |
| 2011-09-30 | $0.00B | $0.06B | 6.43% |
| 2011-06-30 | $0.01B | $0.06B | 8.10% |
| 2011-03-31 | $0.01B | $0.06B | 9.88% |
| 2010-12-31 | $0.01B | $0.06B | 11.72% |
| 2010-09-30 | $0.01B | $0.06B | 10.30% |
| 2010-06-30 | $0.01B | $0.06B | 8.77% |
| 2010-03-31 | $0.00B | $0.06B | 7.14% |
| 2009-12-31 | $0.00B | $0.06B | 1.83% |
| 2009-09-30 | $0.00B | $0.06B | 0.00% |
| 2009-06-30 | $-0.00B | $0.05B | -1.88% |
| 2009-03-31 | $-0.00B | $0.05B | -5.58% |
| 2008-12-31 | $-0.00B | $0.05B | -7.24% |
| 2008-09-30 | $-0.01B | $0.05B | -8.77% |
| 2008-06-30 | $-0.01B | $0.06B | -10.39% |
| 2008-03-31 | $-0.01B | $0.06B | -8.66% |
| 2007-12-31 | $-0.00B | $0.06B | -5.22% |
| 2007-06-30 | $-0.00B | $0.06B | -4.73% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.737B | $0.106B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $159.545B | 22.04 |
| Abbott Laboratories (ABT) | United States | $157.393B | 28.71 |
| Stryker (SYK) | United States | $79.374B | 26.69 |
| Boston Scientific (BSX) | United States | $61.719B | 29.13 |
| Baxter (BAX) | United States | $45.812B | 27.78 |
| Essilor Luxottica (ESLOY) | France | $35.128B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $30.725B | 19.27 |
| Lonza Group Ag (LZAGY) | Switzerland | $28.134B | 0.00 |
| Coloplast (CLPBY) | Denmark | $27.648B | 42.67 |
| Terumo (TRUMY) | Japan | $26.986B | 0.00 |
| ResMed (RMD) | United States | $23.088B | 42.59 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $21.557B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $20.017B | 0.00 |
| Insulet (PODD) | United States | $11.669B | 555.18 |
| Bio-Rad Laboratories (BIO) | United States | $11.282B | 54.15 |
| Canopy Growth (CGC) | Canada | $8.676B | 0.00 |
| Perrigo (PRGO) | Ireland | $8.033B | 14.98 |
| William Demant Holdings (WILYY) | Denmark | $7.896B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.750B | 22.78 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.357B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $6.158B | 0.00 |
| Haemonetics (HAE) | United States | $5.770B | 38.99 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| NuVasive (NUVA) | United States | $4.065B | 32.01 |
| ICU Medical (ICUI) | United States | $3.960B | 25.81 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.923B | 0.00 |
| Neogen (NEOG) | United States | $3.757B | 62.53 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.675B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.113B | 0.00 |
| Quidel (QDEL) | United States | $3.020B | 28.66 |
| National Vision Holdings (EYE) | United States | $2.597B | 58.63 |
| Aurora Cannabis (ACB) | Canada | $2.321B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.887B | 0.00 |
| AtriCure (ATRC) | United States | $1.513B | 0.00 |
| InMode (INMD) | Israel | $1.440B | 0.00 |
| TG Therapeutics (TGTX) | United States | $1.364B | 0.00 |
| Aphria (APHA) | $1.331B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.206B | 24.09 |
| NanoString Technologies (NSTG) | United States | $1.101B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.043B | 19.54 |
| PetIQ (PETQ) | United States | $0.869B | 21.20 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.806B | 30.87 |
| Lantheus Holdings (LNTH) | United States | $0.742B | 18.54 |
| Omeros (OMER) | United States | $0.678B | 0.00 |
| Quanterix (QTRX) | United States | $0.675B | 0.00 |
| Cerus (CERS) | United States | $0.571B | 0.00 |
| Surmodics (SRDX) | United States | $0.560B | 58.06 |
| MacroGenics (MGNX) | United States | $0.551B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.509B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.507B | 30.44 |
| HEXO (HEXO) | $0.441B | 0.00 | |
| Meridian Bioscience (VIVO) | United States | $0.424B | 14.54 |
| Utah Medical Products (UTMD) | United States | $0.392B | 28.37 |
| Zynex (ZYXI) | United States | $0.350B | 39.59 |
| Owens & Minor (OMI) | United States | $0.346B | 12.81 |
| BioLife Solutions (BLFS) | United States | $0.332B | 135.08 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.285B | 0.00 |
| Bovie Medical (APYX) | United States | $0.277B | 0.00 |
| Female Health (VERU) | United States | $0.273B | 0.00 |
| Vapotherm (VAPO) | United States | $0.259B | 0.00 |
| United Health Products (UEEC) | United States | $0.233B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.225B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.209B | 22.04 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.178B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.177B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.166B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.149B | 0.00 |
| Fonar (FONR) | United States | $0.134B | 9.43 |
| Chimerix (CMRX) | United States | $0.125B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Surface Oncology (SURF) | United States | $0.094B | 0.00 |
| United-Guardian (UG) | United States | $0.089B | 22.57 |
| MRI Interventions (MRIC) | United States | $0.086B | 0.00 |
| Nephros (NEPH) | United States | $0.074B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.069B | 0.00 |
| FSD PHARMA INC (HUGE) | $0.051B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.036B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.025B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.023B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.023B | 0.00 |
| Senestech (SNES) | United States | $0.016B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.014B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.008B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
